Drisapersen Duchenne Muscular Dystrophy (DMD) Treatment Protocol

Clinical trial NCT01890798 · WITHDRAWN

Trial details

NCT number: NCT01890798
Sponsor: GlaxoSmithKline
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Muscular Dystrophies

Start date: 2014-01-01
Primary completion: 2014-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.